Medical Devices & Consumables
Global Neuromodulation Devices Market Research Report 2025
- Aug 20, 25
- ID: 458367
- Pages: 83
- Figures: 84
- Views: 1
Report Scope
This report aims to provide a comprehensive presentation of the global market for Neuromodulation Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neuromodulation Devices.
The Neuromodulation Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Neuromodulation Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neuromodulation Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Medtronic
Boston Scientific
Abbott
LivaNova
Nevro
NeuroPace
Beijing Pins
Synapse Biomedical
Segment by Type
Deep Brain Stimulation (DBS)
Spinal Cord Stimulation (SCS)
Vagus Nerve Stimulation (VNS)
Sacral Nerve Stimulation (SNS)
Gastric Electrical Stimulation (GES)
Segment by Application
Pain Management
Parkinson’s Disease
Urinary and Fecal Incontinence
Epilepsy
Gastroparesis
Other
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Neuromodulation Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Neuromodulation Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
This report aims to provide a comprehensive presentation of the global market for Neuromodulation Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neuromodulation Devices.
The Neuromodulation Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Neuromodulation Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neuromodulation Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Medtronic
Boston Scientific
Abbott
LivaNova
Nevro
NeuroPace
Beijing Pins
Synapse Biomedical
Segment by Type
Deep Brain Stimulation (DBS)
Spinal Cord Stimulation (SCS)
Vagus Nerve Stimulation (VNS)
Sacral Nerve Stimulation (SNS)
Gastric Electrical Stimulation (GES)
Segment by Application
Pain Management
Parkinson’s Disease
Urinary and Fecal Incontinence
Epilepsy
Gastroparesis
Other
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Neuromodulation Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Neuromodulation Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Neuromodulation Devices Market Overview
1.1 Product Definition
1.2 Neuromodulation Devices by Type
1.2.1 Global Neuromodulation Devices Market Value Comparison by Type (2024 VS 2031)
1.2.2 Deep Brain Stimulation (DBS)
1.2.3 Spinal Cord Stimulation (SCS)
1.2.4 Vagus Nerve Stimulation (VNS)
1.2.5 Sacral Nerve Stimulation (SNS)
1.2.6 Gastric Electrical Stimulation (GES)
1.3 Neuromodulation Devices by Application
1.3.1 Global Neuromodulation Devices Market Value by Application (2024 VS 2031)
1.3.2 Pain Management
1.3.3 Parkinson’s Disease
1.3.4 Urinary and Fecal Incontinence
1.3.5 Epilepsy
1.3.6 Gastroparesis
1.3.7 Other
1.4 Global Neuromodulation Devices Market Size Estimates and Forecasts
1.4.1 Global Neuromodulation Devices Revenue 2020-2031
1.4.2 Global Neuromodulation Devices Sales 2020-2031
1.4.3 Global Neuromodulation Devices Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Neuromodulation Devices Market Competition by Manufacturers
2.1 Global Neuromodulation Devices Sales Market Share by Manufacturers (2020-2025)
2.2 Global Neuromodulation Devices Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Neuromodulation Devices Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Neuromodulation Devices, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Neuromodulation Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Neuromodulation Devices, Product Type & Application
2.7 Global Key Manufacturers of Neuromodulation Devices, Date of Enter into This Industry
2.8 Global Neuromodulation Devices Market Competitive Situation and Trends
2.8.1 Global Neuromodulation Devices Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Neuromodulation Devices Players Market Share by Revenue
2.8.3 Global Neuromodulation Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Neuromodulation Devices Market Scenario by Region
3.1 Global Neuromodulation Devices Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Neuromodulation Devices Sales by Region: 2020-2031
3.2.1 Global Neuromodulation Devices Sales by Region: 2020-2025
3.2.2 Global Neuromodulation Devices Sales by Region: 2026-2031
3.3 Global Neuromodulation Devices Revenue by Region: 2020-2031
3.3.1 Global Neuromodulation Devices Revenue by Region: 2020-2025
3.3.2 Global Neuromodulation Devices Revenue by Region: 2026-2031
3.4 North America Neuromodulation Devices Market Facts & Figures by Country
3.4.1 North America Neuromodulation Devices Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Neuromodulation Devices Sales by Country (2020-2031)
3.4.3 North America Neuromodulation Devices Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Neuromodulation Devices Market Facts & Figures by Country
3.5.1 Europe Neuromodulation Devices Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Neuromodulation Devices Sales by Country (2020-2031)
3.5.3 Europe Neuromodulation Devices Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Neuromodulation Devices Market Facts & Figures by Region
3.6.1 Asia Pacific Neuromodulation Devices Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Neuromodulation Devices Sales by Region (2020-2031)
3.6.3 Asia Pacific Neuromodulation Devices Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Neuromodulation Devices Market Facts & Figures by Country
3.7.1 Latin America Neuromodulation Devices Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Neuromodulation Devices Sales by Country (2020-2031)
3.7.3 Latin America Neuromodulation Devices Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Neuromodulation Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Neuromodulation Devices Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Neuromodulation Devices Sales by Country (2020-2031)
3.8.3 Middle East and Africa Neuromodulation Devices Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Neuromodulation Devices Sales by Type (2020-2031)
4.1.1 Global Neuromodulation Devices Sales by Type (2020-2025)
4.1.2 Global Neuromodulation Devices Sales by Type (2026-2031)
4.1.3 Global Neuromodulation Devices Sales Market Share by Type (2020-2031)
4.2 Global Neuromodulation Devices Revenue by Type (2020-2031)
4.2.1 Global Neuromodulation Devices Revenue by Type (2020-2025)
4.2.2 Global Neuromodulation Devices Revenue by Type (2026-2031)
4.2.3 Global Neuromodulation Devices Revenue Market Share by Type (2020-2031)
4.3 Global Neuromodulation Devices Price by Type (2020-2031)
5 Segment by Application
5.1 Global Neuromodulation Devices Sales by Application (2020-2031)
5.1.1 Global Neuromodulation Devices Sales by Application (2020-2025)
5.1.2 Global Neuromodulation Devices Sales by Application (2026-2031)
5.1.3 Global Neuromodulation Devices Sales Market Share by Application (2020-2031)
5.2 Global Neuromodulation Devices Revenue by Application (2020-2031)
5.2.1 Global Neuromodulation Devices Revenue by Application (2020-2025)
5.2.2 Global Neuromodulation Devices Revenue by Application (2026-2031)
5.2.3 Global Neuromodulation Devices Revenue Market Share by Application (2020-2031)
5.3 Global Neuromodulation Devices Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Company Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Neuromodulation Devices Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Medtronic Neuromodulation Devices Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 Boston Scientific
6.2.1 Boston Scientific Company Information
6.2.2 Boston Scientific Description and Business Overview
6.2.3 Boston Scientific Neuromodulation Devices Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Boston Scientific Neuromodulation Devices Product Portfolio
6.2.5 Boston Scientific Recent Developments/Updates
6.3 Abbott
6.3.1 Abbott Company Information
6.3.2 Abbott Description and Business Overview
6.3.3 Abbott Neuromodulation Devices Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Abbott Neuromodulation Devices Product Portfolio
6.3.5 Abbott Recent Developments/Updates
6.4 LivaNova
6.4.1 LivaNova Company Information
6.4.2 LivaNova Description and Business Overview
6.4.3 LivaNova Neuromodulation Devices Sales, Revenue and Gross Margin (2020-2025)
6.4.4 LivaNova Neuromodulation Devices Product Portfolio
6.4.5 LivaNova Recent Developments/Updates
6.5 Nevro
6.5.1 Nevro Company Information
6.5.2 Nevro Description and Business Overview
6.5.3 Nevro Neuromodulation Devices Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Nevro Neuromodulation Devices Product Portfolio
6.5.5 Nevro Recent Developments/Updates
6.6 NeuroPace
6.6.1 NeuroPace Company Information
6.6.2 NeuroPace Description and Business Overview
6.6.3 NeuroPace Neuromodulation Devices Sales, Revenue and Gross Margin (2020-2025)
6.6.4 NeuroPace Neuromodulation Devices Product Portfolio
6.6.5 NeuroPace Recent Developments/Updates
6.7 Beijing Pins
6.7.1 Beijing Pins Company Information
6.7.2 Beijing Pins Description and Business Overview
6.7.3 Beijing Pins Neuromodulation Devices Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Beijing Pins Neuromodulation Devices Product Portfolio
6.7.5 Beijing Pins Recent Developments/Updates
6.8 Synapse Biomedical
6.8.1 Synapse Biomedical Company Information
6.8.2 Synapse Biomedical Description and Business Overview
6.8.3 Synapse Biomedical Neuromodulation Devices Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Synapse Biomedical Neuromodulation Devices Product Portfolio
6.8.5 Synapse Biomedical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Neuromodulation Devices Industry Chain Analysis
7.2 Neuromodulation Devices Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Neuromodulation Devices Production Mode & Process Analysis
7.4 Neuromodulation Devices Sales and Marketing
7.4.1 Neuromodulation Devices Sales Channels
7.4.2 Neuromodulation Devices Distributors
7.5 Neuromodulation Devices Customer Analysis
8 Neuromodulation Devices Market Dynamics
8.1 Neuromodulation Devices Industry Trends
8.2 Neuromodulation Devices Market Drivers
8.3 Neuromodulation Devices Market Challenges
8.4 Neuromodulation Devices Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Neuromodulation Devices by Type
1.2.1 Global Neuromodulation Devices Market Value Comparison by Type (2024 VS 2031)
1.2.2 Deep Brain Stimulation (DBS)
1.2.3 Spinal Cord Stimulation (SCS)
1.2.4 Vagus Nerve Stimulation (VNS)
1.2.5 Sacral Nerve Stimulation (SNS)
1.2.6 Gastric Electrical Stimulation (GES)
1.3 Neuromodulation Devices by Application
1.3.1 Global Neuromodulation Devices Market Value by Application (2024 VS 2031)
1.3.2 Pain Management
1.3.3 Parkinson’s Disease
1.3.4 Urinary and Fecal Incontinence
1.3.5 Epilepsy
1.3.6 Gastroparesis
1.3.7 Other
1.4 Global Neuromodulation Devices Market Size Estimates and Forecasts
1.4.1 Global Neuromodulation Devices Revenue 2020-2031
1.4.2 Global Neuromodulation Devices Sales 2020-2031
1.4.3 Global Neuromodulation Devices Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Neuromodulation Devices Market Competition by Manufacturers
2.1 Global Neuromodulation Devices Sales Market Share by Manufacturers (2020-2025)
2.2 Global Neuromodulation Devices Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Neuromodulation Devices Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Neuromodulation Devices, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Neuromodulation Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Neuromodulation Devices, Product Type & Application
2.7 Global Key Manufacturers of Neuromodulation Devices, Date of Enter into This Industry
2.8 Global Neuromodulation Devices Market Competitive Situation and Trends
2.8.1 Global Neuromodulation Devices Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Neuromodulation Devices Players Market Share by Revenue
2.8.3 Global Neuromodulation Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Neuromodulation Devices Market Scenario by Region
3.1 Global Neuromodulation Devices Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Neuromodulation Devices Sales by Region: 2020-2031
3.2.1 Global Neuromodulation Devices Sales by Region: 2020-2025
3.2.2 Global Neuromodulation Devices Sales by Region: 2026-2031
3.3 Global Neuromodulation Devices Revenue by Region: 2020-2031
3.3.1 Global Neuromodulation Devices Revenue by Region: 2020-2025
3.3.2 Global Neuromodulation Devices Revenue by Region: 2026-2031
3.4 North America Neuromodulation Devices Market Facts & Figures by Country
3.4.1 North America Neuromodulation Devices Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Neuromodulation Devices Sales by Country (2020-2031)
3.4.3 North America Neuromodulation Devices Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Neuromodulation Devices Market Facts & Figures by Country
3.5.1 Europe Neuromodulation Devices Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Neuromodulation Devices Sales by Country (2020-2031)
3.5.3 Europe Neuromodulation Devices Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Neuromodulation Devices Market Facts & Figures by Region
3.6.1 Asia Pacific Neuromodulation Devices Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Neuromodulation Devices Sales by Region (2020-2031)
3.6.3 Asia Pacific Neuromodulation Devices Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Neuromodulation Devices Market Facts & Figures by Country
3.7.1 Latin America Neuromodulation Devices Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Neuromodulation Devices Sales by Country (2020-2031)
3.7.3 Latin America Neuromodulation Devices Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Neuromodulation Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Neuromodulation Devices Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Neuromodulation Devices Sales by Country (2020-2031)
3.8.3 Middle East and Africa Neuromodulation Devices Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Neuromodulation Devices Sales by Type (2020-2031)
4.1.1 Global Neuromodulation Devices Sales by Type (2020-2025)
4.1.2 Global Neuromodulation Devices Sales by Type (2026-2031)
4.1.3 Global Neuromodulation Devices Sales Market Share by Type (2020-2031)
4.2 Global Neuromodulation Devices Revenue by Type (2020-2031)
4.2.1 Global Neuromodulation Devices Revenue by Type (2020-2025)
4.2.2 Global Neuromodulation Devices Revenue by Type (2026-2031)
4.2.3 Global Neuromodulation Devices Revenue Market Share by Type (2020-2031)
4.3 Global Neuromodulation Devices Price by Type (2020-2031)
5 Segment by Application
5.1 Global Neuromodulation Devices Sales by Application (2020-2031)
5.1.1 Global Neuromodulation Devices Sales by Application (2020-2025)
5.1.2 Global Neuromodulation Devices Sales by Application (2026-2031)
5.1.3 Global Neuromodulation Devices Sales Market Share by Application (2020-2031)
5.2 Global Neuromodulation Devices Revenue by Application (2020-2031)
5.2.1 Global Neuromodulation Devices Revenue by Application (2020-2025)
5.2.2 Global Neuromodulation Devices Revenue by Application (2026-2031)
5.2.3 Global Neuromodulation Devices Revenue Market Share by Application (2020-2031)
5.3 Global Neuromodulation Devices Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Company Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Neuromodulation Devices Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Medtronic Neuromodulation Devices Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 Boston Scientific
6.2.1 Boston Scientific Company Information
6.2.2 Boston Scientific Description and Business Overview
6.2.3 Boston Scientific Neuromodulation Devices Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Boston Scientific Neuromodulation Devices Product Portfolio
6.2.5 Boston Scientific Recent Developments/Updates
6.3 Abbott
6.3.1 Abbott Company Information
6.3.2 Abbott Description and Business Overview
6.3.3 Abbott Neuromodulation Devices Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Abbott Neuromodulation Devices Product Portfolio
6.3.5 Abbott Recent Developments/Updates
6.4 LivaNova
6.4.1 LivaNova Company Information
6.4.2 LivaNova Description and Business Overview
6.4.3 LivaNova Neuromodulation Devices Sales, Revenue and Gross Margin (2020-2025)
6.4.4 LivaNova Neuromodulation Devices Product Portfolio
6.4.5 LivaNova Recent Developments/Updates
6.5 Nevro
6.5.1 Nevro Company Information
6.5.2 Nevro Description and Business Overview
6.5.3 Nevro Neuromodulation Devices Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Nevro Neuromodulation Devices Product Portfolio
6.5.5 Nevro Recent Developments/Updates
6.6 NeuroPace
6.6.1 NeuroPace Company Information
6.6.2 NeuroPace Description and Business Overview
6.6.3 NeuroPace Neuromodulation Devices Sales, Revenue and Gross Margin (2020-2025)
6.6.4 NeuroPace Neuromodulation Devices Product Portfolio
6.6.5 NeuroPace Recent Developments/Updates
6.7 Beijing Pins
6.7.1 Beijing Pins Company Information
6.7.2 Beijing Pins Description and Business Overview
6.7.3 Beijing Pins Neuromodulation Devices Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Beijing Pins Neuromodulation Devices Product Portfolio
6.7.5 Beijing Pins Recent Developments/Updates
6.8 Synapse Biomedical
6.8.1 Synapse Biomedical Company Information
6.8.2 Synapse Biomedical Description and Business Overview
6.8.3 Synapse Biomedical Neuromodulation Devices Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Synapse Biomedical Neuromodulation Devices Product Portfolio
6.8.5 Synapse Biomedical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Neuromodulation Devices Industry Chain Analysis
7.2 Neuromodulation Devices Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Neuromodulation Devices Production Mode & Process Analysis
7.4 Neuromodulation Devices Sales and Marketing
7.4.1 Neuromodulation Devices Sales Channels
7.4.2 Neuromodulation Devices Distributors
7.5 Neuromodulation Devices Customer Analysis
8 Neuromodulation Devices Market Dynamics
8.1 Neuromodulation Devices Industry Trends
8.2 Neuromodulation Devices Market Drivers
8.3 Neuromodulation Devices Market Challenges
8.4 Neuromodulation Devices Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Neuromodulation Devices Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Neuromodulation Devices Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Neuromodulation Devices Market Competitive Situation by Manufacturers in 2024
Table 4. Global Neuromodulation Devices Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Neuromodulation Devices Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Neuromodulation Devices Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Neuromodulation Devices Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Neuromodulation Devices Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Neuromodulation Devices, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Neuromodulation Devices, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Neuromodulation Devices, Product Type & Application
Table 12. Global Key Manufacturers of Neuromodulation Devices, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Neuromodulation Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuromodulation Devices as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Neuromodulation Devices Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Neuromodulation Devices Sales by Region (2020-2025) & (K Units)
Table 18. Global Neuromodulation Devices Sales Market Share by Region (2020-2025)
Table 19. Global Neuromodulation Devices Sales by Region (2026-2031) & (K Units)
Table 20. Global Neuromodulation Devices Sales Market Share by Region (2026-2031)
Table 21. Global Neuromodulation Devices Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Neuromodulation Devices Revenue Market Share by Region (2020-2025)
Table 23. Global Neuromodulation Devices Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Neuromodulation Devices Revenue Market Share by Region (2026-2031)
Table 25. North America Neuromodulation Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Neuromodulation Devices Sales by Country (2020-2025) & (K Units)
Table 27. North America Neuromodulation Devices Sales by Country (2026-2031) & (K Units)
Table 28. North America Neuromodulation Devices Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Neuromodulation Devices Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Neuromodulation Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Neuromodulation Devices Sales by Country (2020-2025) & (K Units)
Table 32. Europe Neuromodulation Devices Sales by Country (2026-2031) & (K Units)
Table 33. Europe Neuromodulation Devices Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Neuromodulation Devices Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Neuromodulation Devices Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Neuromodulation Devices Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Neuromodulation Devices Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Neuromodulation Devices Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Neuromodulation Devices Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Neuromodulation Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Neuromodulation Devices Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Neuromodulation Devices Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Neuromodulation Devices Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Neuromodulation Devices Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Neuromodulation Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Neuromodulation Devices Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Neuromodulation Devices Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Neuromodulation Devices Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Neuromodulation Devices Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Neuromodulation Devices Sales (K Units) by Type (2020-2025)
Table 51. Global Neuromodulation Devices Sales (K Units) by Type (2026-2031)
Table 52. Global Neuromodulation Devices Sales Market Share by Type (2020-2025)
Table 53. Global Neuromodulation Devices Sales Market Share by Type (2026-2031)
Table 54. Global Neuromodulation Devices Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Neuromodulation Devices Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Neuromodulation Devices Revenue Market Share by Type (2020-2025)
Table 57. Global Neuromodulation Devices Revenue Market Share by Type (2026-2031)
Table 58. Global Neuromodulation Devices Price (USD/Unit) by Type (2020-2025)
Table 59. Global Neuromodulation Devices Price (USD/Unit) by Type (2026-2031)
Table 60. Global Neuromodulation Devices Sales (K Units) by Application (2020-2025)
Table 61. Global Neuromodulation Devices Sales (K Units) by Application (2026-2031)
Table 62. Global Neuromodulation Devices Sales Market Share by Application (2020-2025)
Table 63. Global Neuromodulation Devices Sales Market Share by Application (2026-2031)
Table 64. Global Neuromodulation Devices Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Neuromodulation Devices Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Neuromodulation Devices Revenue Market Share by Application (2020-2025)
Table 67. Global Neuromodulation Devices Revenue Market Share by Application (2026-2031)
Table 68. Global Neuromodulation Devices Price (USD/Unit) by Application (2020-2025)
Table 69. Global Neuromodulation Devices Price (USD/Unit) by Application (2026-2031)
Table 70. Medtronic Company Information
Table 71. Medtronic Description and Business Overview
Table 72. Medtronic Neuromodulation Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Medtronic Neuromodulation Devices Product
Table 74. Medtronic Recent Developments/Updates
Table 75. Boston Scientific Company Information
Table 76. Boston Scientific Description and Business Overview
Table 77. Boston Scientific Neuromodulation Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Boston Scientific Neuromodulation Devices Product
Table 79. Boston Scientific Recent Developments/Updates
Table 80. Abbott Company Information
Table 81. Abbott Description and Business Overview
Table 82. Abbott Neuromodulation Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Abbott Neuromodulation Devices Product
Table 84. Abbott Recent Developments/Updates
Table 85. LivaNova Company Information
Table 86. LivaNova Description and Business Overview
Table 87. LivaNova Neuromodulation Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. LivaNova Neuromodulation Devices Product
Table 89. LivaNova Recent Developments/Updates
Table 90. Nevro Company Information
Table 91. Nevro Description and Business Overview
Table 92. Nevro Neuromodulation Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Nevro Neuromodulation Devices Product
Table 94. Nevro Recent Developments/Updates
Table 95. NeuroPace Company Information
Table 96. NeuroPace Description and Business Overview
Table 97. NeuroPace Neuromodulation Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. NeuroPace Neuromodulation Devices Product
Table 99. NeuroPace Recent Developments/Updates
Table 100. Beijing Pins Company Information
Table 101. Beijing Pins Description and Business Overview
Table 102. Beijing Pins Neuromodulation Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Beijing Pins Neuromodulation Devices Product
Table 104. Beijing Pins Recent Developments/Updates
Table 105. Synapse Biomedical Company Information
Table 106. Synapse Biomedical Description and Business Overview
Table 107. Synapse Biomedical Neuromodulation Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Synapse Biomedical Neuromodulation Devices Product
Table 109. Synapse Biomedical Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Neuromodulation Devices Distributors List
Table 113. Neuromodulation Devices Customers List
Table 114. Neuromodulation Devices Market Trends
Table 115. Neuromodulation Devices Market Drivers
Table 116. Neuromodulation Devices Market Challenges
Table 117. Neuromodulation Devices Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Product Picture of Neuromodulation Devices
Figure 2. Global Neuromodulation Devices Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Neuromodulation Devices Market Share by Type: 2024 & 2031
Figure 4. Deep Brain Stimulation (DBS) Product Picture
Figure 5. Spinal Cord Stimulation (SCS) Product Picture
Figure 6. Vagus Nerve Stimulation (VNS) Product Picture
Figure 7. Sacral Nerve Stimulation (SNS) Product Picture
Figure 8. Gastric Electrical Stimulation (GES) Product Picture
Figure 9. Global Neuromodulation Devices Market Value by Application (2020-2031) & (US$ Million)
Figure 10. Global Neuromodulation Devices Market Share by Application: 2024 & 2031
Figure 11. Pain Management
Figure 12. Parkinson’s Disease
Figure 13. Urinary and Fecal Incontinence
Figure 14. Epilepsy
Figure 15. Gastroparesis
Figure 16. Other
Figure 17. Global Neuromodulation Devices Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Neuromodulation Devices Market Size (2020-2031) & (US$ Million)
Figure 19. Global Neuromodulation Devices Sales (2020-2031) & (K Units)
Figure 20. Global Neuromodulation Devices Average Price (USD/Unit) & (2020-2031)
Figure 21. Neuromodulation Devices Report Years Considered
Figure 22. Neuromodulation Devices Sales Share by Manufacturers in 2024
Figure 23. Global Neuromodulation Devices Revenue Share by Manufacturers in 2024
Figure 24. Global 5 and 10 Largest Neuromodulation Devices Players: Market Share by Revenue in Neuromodulation Devices in 2024
Figure 25. Neuromodulation Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 26. Global Neuromodulation Devices Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 27. North America Neuromodulation Devices Sales Market Share by Country (2020-2031)
Figure 28. North America Neuromodulation Devices Revenue Market Share by Country (2020-2031)
Figure 29. U.S. Neuromodulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Canada Neuromodulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Europe Neuromodulation Devices Sales Market Share by Country (2020-2031)
Figure 32. Europe Neuromodulation Devices Revenue Market Share by Country (2020-2031)
Figure 33. Germany Neuromodulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. France Neuromodulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. U.K. Neuromodulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Italy Neuromodulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Russia Neuromodulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Asia Pacific Neuromodulation Devices Sales Market Share by Region (2020-2031)
Figure 39. Asia Pacific Neuromodulation Devices Revenue Market Share by Region (2020-2031)
Figure 40. China Neuromodulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Japan Neuromodulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. South Korea Neuromodulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. India Neuromodulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Australia Neuromodulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Taiwan Neuromodulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Indonesia Neuromodulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Thailand Neuromodulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Malaysia Neuromodulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Philippines Neuromodulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Latin America Neuromodulation Devices Sales Market Share by Country (2020-2031)
Figure 51. Latin America Neuromodulation Devices Revenue Market Share by Country (2020-2031)
Figure 52. Mexico Neuromodulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Brazil Neuromodulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Argentina Neuromodulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Middle East and Africa Neuromodulation Devices Sales Market Share by Country (2020-2031)
Figure 56. Middle East and Africa Neuromodulation Devices Revenue Market Share by Country (2020-2031)
Figure 57. Turkey Neuromodulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. Saudi Arabia Neuromodulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 59. UAE Neuromodulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 60. Global Sales Market Share of Neuromodulation Devices by Type (2020-2031)
Figure 61. Global Revenue Market Share of Neuromodulation Devices by Type (2020-2031)
Figure 62. Global Neuromodulation Devices Price (USD/Unit) by Type (2020-2031)
Figure 63. Global Sales Market Share of Neuromodulation Devices by Application (2020-2031)
Figure 64. Global Revenue Market Share of Neuromodulation Devices by Application (2020-2031)
Figure 65. Global Neuromodulation Devices Price (USD/Unit) by Application (2020-2031)
Figure 66. Neuromodulation Devices Value Chain
Figure 67. Channels of Distribution (Direct Vs Distribution)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Table 1. Global Neuromodulation Devices Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Neuromodulation Devices Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Neuromodulation Devices Market Competitive Situation by Manufacturers in 2024
Table 4. Global Neuromodulation Devices Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Neuromodulation Devices Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Neuromodulation Devices Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Neuromodulation Devices Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Neuromodulation Devices Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Neuromodulation Devices, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Neuromodulation Devices, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Neuromodulation Devices, Product Type & Application
Table 12. Global Key Manufacturers of Neuromodulation Devices, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Neuromodulation Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuromodulation Devices as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Neuromodulation Devices Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Neuromodulation Devices Sales by Region (2020-2025) & (K Units)
Table 18. Global Neuromodulation Devices Sales Market Share by Region (2020-2025)
Table 19. Global Neuromodulation Devices Sales by Region (2026-2031) & (K Units)
Table 20. Global Neuromodulation Devices Sales Market Share by Region (2026-2031)
Table 21. Global Neuromodulation Devices Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Neuromodulation Devices Revenue Market Share by Region (2020-2025)
Table 23. Global Neuromodulation Devices Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Neuromodulation Devices Revenue Market Share by Region (2026-2031)
Table 25. North America Neuromodulation Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Neuromodulation Devices Sales by Country (2020-2025) & (K Units)
Table 27. North America Neuromodulation Devices Sales by Country (2026-2031) & (K Units)
Table 28. North America Neuromodulation Devices Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Neuromodulation Devices Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Neuromodulation Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Neuromodulation Devices Sales by Country (2020-2025) & (K Units)
Table 32. Europe Neuromodulation Devices Sales by Country (2026-2031) & (K Units)
Table 33. Europe Neuromodulation Devices Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Neuromodulation Devices Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Neuromodulation Devices Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Neuromodulation Devices Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Neuromodulation Devices Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Neuromodulation Devices Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Neuromodulation Devices Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Neuromodulation Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Neuromodulation Devices Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Neuromodulation Devices Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Neuromodulation Devices Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Neuromodulation Devices Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Neuromodulation Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Neuromodulation Devices Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Neuromodulation Devices Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Neuromodulation Devices Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Neuromodulation Devices Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Neuromodulation Devices Sales (K Units) by Type (2020-2025)
Table 51. Global Neuromodulation Devices Sales (K Units) by Type (2026-2031)
Table 52. Global Neuromodulation Devices Sales Market Share by Type (2020-2025)
Table 53. Global Neuromodulation Devices Sales Market Share by Type (2026-2031)
Table 54. Global Neuromodulation Devices Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Neuromodulation Devices Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Neuromodulation Devices Revenue Market Share by Type (2020-2025)
Table 57. Global Neuromodulation Devices Revenue Market Share by Type (2026-2031)
Table 58. Global Neuromodulation Devices Price (USD/Unit) by Type (2020-2025)
Table 59. Global Neuromodulation Devices Price (USD/Unit) by Type (2026-2031)
Table 60. Global Neuromodulation Devices Sales (K Units) by Application (2020-2025)
Table 61. Global Neuromodulation Devices Sales (K Units) by Application (2026-2031)
Table 62. Global Neuromodulation Devices Sales Market Share by Application (2020-2025)
Table 63. Global Neuromodulation Devices Sales Market Share by Application (2026-2031)
Table 64. Global Neuromodulation Devices Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Neuromodulation Devices Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Neuromodulation Devices Revenue Market Share by Application (2020-2025)
Table 67. Global Neuromodulation Devices Revenue Market Share by Application (2026-2031)
Table 68. Global Neuromodulation Devices Price (USD/Unit) by Application (2020-2025)
Table 69. Global Neuromodulation Devices Price (USD/Unit) by Application (2026-2031)
Table 70. Medtronic Company Information
Table 71. Medtronic Description and Business Overview
Table 72. Medtronic Neuromodulation Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Medtronic Neuromodulation Devices Product
Table 74. Medtronic Recent Developments/Updates
Table 75. Boston Scientific Company Information
Table 76. Boston Scientific Description and Business Overview
Table 77. Boston Scientific Neuromodulation Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Boston Scientific Neuromodulation Devices Product
Table 79. Boston Scientific Recent Developments/Updates
Table 80. Abbott Company Information
Table 81. Abbott Description and Business Overview
Table 82. Abbott Neuromodulation Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Abbott Neuromodulation Devices Product
Table 84. Abbott Recent Developments/Updates
Table 85. LivaNova Company Information
Table 86. LivaNova Description and Business Overview
Table 87. LivaNova Neuromodulation Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. LivaNova Neuromodulation Devices Product
Table 89. LivaNova Recent Developments/Updates
Table 90. Nevro Company Information
Table 91. Nevro Description and Business Overview
Table 92. Nevro Neuromodulation Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Nevro Neuromodulation Devices Product
Table 94. Nevro Recent Developments/Updates
Table 95. NeuroPace Company Information
Table 96. NeuroPace Description and Business Overview
Table 97. NeuroPace Neuromodulation Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. NeuroPace Neuromodulation Devices Product
Table 99. NeuroPace Recent Developments/Updates
Table 100. Beijing Pins Company Information
Table 101. Beijing Pins Description and Business Overview
Table 102. Beijing Pins Neuromodulation Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Beijing Pins Neuromodulation Devices Product
Table 104. Beijing Pins Recent Developments/Updates
Table 105. Synapse Biomedical Company Information
Table 106. Synapse Biomedical Description and Business Overview
Table 107. Synapse Biomedical Neuromodulation Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Synapse Biomedical Neuromodulation Devices Product
Table 109. Synapse Biomedical Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Neuromodulation Devices Distributors List
Table 113. Neuromodulation Devices Customers List
Table 114. Neuromodulation Devices Market Trends
Table 115. Neuromodulation Devices Market Drivers
Table 116. Neuromodulation Devices Market Challenges
Table 117. Neuromodulation Devices Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Product Picture of Neuromodulation Devices
Figure 2. Global Neuromodulation Devices Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Neuromodulation Devices Market Share by Type: 2024 & 2031
Figure 4. Deep Brain Stimulation (DBS) Product Picture
Figure 5. Spinal Cord Stimulation (SCS) Product Picture
Figure 6. Vagus Nerve Stimulation (VNS) Product Picture
Figure 7. Sacral Nerve Stimulation (SNS) Product Picture
Figure 8. Gastric Electrical Stimulation (GES) Product Picture
Figure 9. Global Neuromodulation Devices Market Value by Application (2020-2031) & (US$ Million)
Figure 10. Global Neuromodulation Devices Market Share by Application: 2024 & 2031
Figure 11. Pain Management
Figure 12. Parkinson’s Disease
Figure 13. Urinary and Fecal Incontinence
Figure 14. Epilepsy
Figure 15. Gastroparesis
Figure 16. Other
Figure 17. Global Neuromodulation Devices Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Neuromodulation Devices Market Size (2020-2031) & (US$ Million)
Figure 19. Global Neuromodulation Devices Sales (2020-2031) & (K Units)
Figure 20. Global Neuromodulation Devices Average Price (USD/Unit) & (2020-2031)
Figure 21. Neuromodulation Devices Report Years Considered
Figure 22. Neuromodulation Devices Sales Share by Manufacturers in 2024
Figure 23. Global Neuromodulation Devices Revenue Share by Manufacturers in 2024
Figure 24. Global 5 and 10 Largest Neuromodulation Devices Players: Market Share by Revenue in Neuromodulation Devices in 2024
Figure 25. Neuromodulation Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 26. Global Neuromodulation Devices Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 27. North America Neuromodulation Devices Sales Market Share by Country (2020-2031)
Figure 28. North America Neuromodulation Devices Revenue Market Share by Country (2020-2031)
Figure 29. U.S. Neuromodulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Canada Neuromodulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Europe Neuromodulation Devices Sales Market Share by Country (2020-2031)
Figure 32. Europe Neuromodulation Devices Revenue Market Share by Country (2020-2031)
Figure 33. Germany Neuromodulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. France Neuromodulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. U.K. Neuromodulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Italy Neuromodulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Russia Neuromodulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Asia Pacific Neuromodulation Devices Sales Market Share by Region (2020-2031)
Figure 39. Asia Pacific Neuromodulation Devices Revenue Market Share by Region (2020-2031)
Figure 40. China Neuromodulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Japan Neuromodulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. South Korea Neuromodulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. India Neuromodulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Australia Neuromodulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Taiwan Neuromodulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Indonesia Neuromodulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Thailand Neuromodulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Malaysia Neuromodulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Philippines Neuromodulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Latin America Neuromodulation Devices Sales Market Share by Country (2020-2031)
Figure 51. Latin America Neuromodulation Devices Revenue Market Share by Country (2020-2031)
Figure 52. Mexico Neuromodulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Brazil Neuromodulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Argentina Neuromodulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Middle East and Africa Neuromodulation Devices Sales Market Share by Country (2020-2031)
Figure 56. Middle East and Africa Neuromodulation Devices Revenue Market Share by Country (2020-2031)
Figure 57. Turkey Neuromodulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. Saudi Arabia Neuromodulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 59. UAE Neuromodulation Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 60. Global Sales Market Share of Neuromodulation Devices by Type (2020-2031)
Figure 61. Global Revenue Market Share of Neuromodulation Devices by Type (2020-2031)
Figure 62. Global Neuromodulation Devices Price (USD/Unit) by Type (2020-2031)
Figure 63. Global Sales Market Share of Neuromodulation Devices by Application (2020-2031)
Figure 64. Global Revenue Market Share of Neuromodulation Devices by Application (2020-2031)
Figure 65. Global Neuromodulation Devices Price (USD/Unit) by Application (2020-2031)
Figure 66. Neuromodulation Devices Value Chain
Figure 67. Channels of Distribution (Direct Vs Distribution)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global AC Signal Relays Market Research Report 2025
Aug 20, 25
Global DC Signal Relays Market Research Report 2025
Aug 20, 25
Global High-Frequency Signal Relays Market Research Report 2025
Aug 20, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232